Tissue injury initiates a cascade of inflammatory mediators and hyperalgesic substances including prostaglandins, cytokines and chemokines. Using microarray and qRT-PCR gene expression analyses, the present study evaluated changes in gene expression of a cascade of cytokines following acute inflammation and the correlation between the changes in the gene expression level and pain intensity in the oral surgery model of tissue injury and acute pain. Tissue injury resulted in a significant upregulation in the gene expression of interleukin-6 (IL-6; 63.3-fold), IL-8 (8.1-fold), chemokine (C-C motif) ligand 2 (CCL2; 8.9-fold), chemokine (C-X-C motif) ligand 1 (CXCL1; 30.5-fold), chemokine (C-X-C motif) ligand 2 (CXCL2; 26-fold) and annexin A1 (ANXA1; 12-fold). The upregulation of IL-6 gene expression was significantly correlated to the upregulation of IL-8, CCL2, CXCL1 and CXCL2 gene expression. Interestingly, the tissue injury-induced upregulation of IL-6, IL-8 and CCL2 gene expression, was positively correlated to pain intensity at 3 h post-surgery, the onset of acute inflammatory pain. However, ketorolac treatment did not have a significant effect on the gene expression of IL-6, IL-8, CCL2, CXCL2 and ANXA1 at the same time point of acute inflammation. These results demonstrate that the upregulation of IL-6, IL-8 and CCL2 gene expression contributes to the development of acute inflammation and inflammatory pain. The lack of effect of ketorolac on the expression of these gene products may be related to the ceiling analgesic effects of non-steroidal anti-inflammatory drugs.
Introduction
Tissue injury initiates the liberation of various inflammatory mediators and hyperalgesic substances including prostaglandins (PGs), cytokines and chemokines [7, 9] , which integrate the inflammatory response. Leukocyte migration to the injured area, which is a characteristic of the inflammatory response, is associated with pain and tenderness, and is involved in wound healing [19, 64, 75] . Chemokines (chemotactic cytokines) are small, secreted proteins that organize trafficking of leukocytes under normal conditions and in response to tissue damage [76] . In general, they are not stored within cells but are synthesized in response to a variety of agents, including pro-inflammatory cytokines [18] .
IL-6 plays a role in controlling leukocyte recruitment pattern during acute inflammation [24] . In vitro studies show that IL-6 secretion is induced by many other inflammatory mediators including IL-1b, tumor necrosis factor-alpha (TNF-a) and PGE 2 [66] . In turn, IL-6 induces the release of chemokines CCL2 and IL-8 [55] . Inflammatory cytokines, including IL-6, are also involved in the modulation of pain [13] . In inflammatory pain models, IL-6 induces a short-lasting prostaglandin (PG) dependent hyperalgesia [9] and local analgesia via opioid secretion, probably from inflammatory cells [11, 51, 65] . Most, if not all, nucleated cells are capable of synthesizing IL-6 at variable rates [13] . Chemokines, particularly IL-8, CCL2 and CXCL1, also participate in inflammatory hypernociception in experimental animals. However, the mechanisms underlying these hypernociceptive effects remain unclear, for review see [70] .
We have recently shown in the oral surgery model, an increase in the protein and/or gene expression of several cytokines and chemokines, 48 h after surgery [72, 73] . However, the pattern of cytokine and chemokine expression in response to inflammation and tissue injury is a dynamic process [24, 25, 39] . It is known that peripheral inflammation induces central sensitization, which is involved in the mechanism of inflammatory hyperalgesia. IL-6, but not TNF-a or IL-1b, was recently reported as a messenger of inflammatory information from the periphery to the central nervous system in carrageenan model of inflammatory hyperalgesia [48] . Since TNF-a and IL-1b are upregulated in the oral mucosa 3 h after surgery [35, 71] , it is therefore of interest to investigate the expression of IL-6 and other inflammatory cytokines and chemokines at this early time point following tissue injury.
